Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

The oral contraceptive improved hair and skin quality in women.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Women with PCOS have lower self-esteem and body image satisfaction.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Better hair loss models needed for research.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.